BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29766776)

  • 1. BK Polyomavirus Immune Response With Stress on BK-Specific T Cells.
    El Hennawy HM
    Exp Clin Transplant; 2018 Aug; 16(4):376-385. PubMed ID: 29766776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
    Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
    Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
    Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T
    Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral infections directly involved in kidney allograft function.
    Masutani K
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():31-37. PubMed ID: 29968408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F; Mohsin N; Kamble P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different behaviour of BK-virus infection in liver transplant recipients.
    Umbro I; Tinti F; Muiesan P; Mitterhofer AP
    World J Gastroenterol; 2016 Jan; 22(4):1532-40. PubMed ID: 26819520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Relationship Between BK Virus and Human Leukocyte Antigens in Kidney Transplant Recipients.
    Kavuzlu M; Baştürk B; Ataç FB; Alışkan HE; Kantaroğlu B
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):51-54. PubMed ID: 32008495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-Scale Rapid Autologous BK Virus-Specific T Cell Line Generation From Kidney Transplant Recipients With Active Viremia for Adoptive Immunotherapy.
    Lamarche C; Orio J; Georges-Tobar V; Pincez T; Goupil M; Dahmani A; Carli C; Brasey A; Busque L; Delisle JS
    Transplantation; 2017 Nov; 101(11):2713-2721. PubMed ID: 28230645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation.
    Schaenman JM; Korin Y; Sidwell T; Kandarian F; Harre N; Gjertson D; Lum EL; Reddy U; Huang E; Pham PT; Bunnapradist S; Danovitch GM; Veale J; Gritsch HA; Reed EF
    Transplantation; 2017 Jun; 101(6):1479-1487. PubMed ID: 27391197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection.
    Jha A; Ahmed W; Pakkyara A; Shaheen F; Al Salmi I
    Saudi J Kidney Dis Transpl; 2018; 29(5):1073-1081. PubMed ID: 30381503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
    Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J
    Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
    Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
    Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Diagnosis of Interstitial Allograft Rejection and BKV Nephropathy by T-cell Receptor Sequencing.
    Stervbo U; Nienen M; Hecht J; Viebahn R; Amann K; Westhoff TH; Babel N
    Transplantation; 2020 Apr; 104(4):e107-e108. PubMed ID: 32224816
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immune responses to BK virus.
    Comoli P; Hirsch HH; Ginevri F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):569-74. PubMed ID: 19060544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK virus-induced renal allograft nephropathy.
    Krejci K; Tichy T; Bednarikova J; Zamboch K; Zadrazil J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):165-177. PubMed ID: 29765170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J; Hill P; Goodman D
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Management of BK Virus Infection.
    Saleh A; El Din Khedr MS; Ezzat A; Takou A; Halawa A
    Exp Clin Transplant; 2020 Nov; 18(6):659-670. PubMed ID: 32552624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
    Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.